Chiral purity

Sodium Levothyroxine. As one of the active principles of the thyroid gland, sodium levothyroxine [55-03-8] (levothyroxine sodium) can be obtained either from the thyroid glands of domesticated animals (10) or synthetically. It should contain 61.6—65.5% iodine, corresponding to 100 3% of the pure salt calculated on an anhydrous basis. Its chiral purity must also be ascertained because partial racemi2ation may occur during synthesis and because dl-T is available commercially. Sodium levothyroxine melts with decomposition at ca 235°C. It is prepared as pentahydrate [6106-07-6] from... 

Analytical Methods. A Schimadzu Liquid Chromatograph was used to monitor the reaction conversion and to assign chemical and chiral purity to the final product. Structures were verified by HNMR spectra obtained on a Bruker (Model UltraShield 400 spectrometer). Optical rotations were measured on a Perkin Elmer Model 341 Polarimeter. 

Possible racemisation of imines, derivatives of amino acids and R(—)-myrtenal, has been examined by Dufrasne et al.1 After 72 h, no significant effect on chiral purity was observed. For imines being derivatives of chiral primary amines and the a-substituted 8-keto-aldehydes, no evidence of epimerisation has been indicated by the NMR measurements.3 For a series of imines, being derivatives of amino acids or amino acid esters and (R)-BINOL reagents, Chin et al.5 have tested the possibility of epimerization under experiment conditions. It was shown that R S ratio has changed only slightly, and after 24 h, the difference was lower than 10%. 

Molecules which exhibit optical activity are molecules which have a handedness in their structure. They are chiral . Chemists often have reasons to obtain chemical pure aliquots of particular molecules. Since the chirality of molecules can influence biological effect in pharmaceuticals, the chiral purity of a drug substance can pose a challenge both in terms of obtaining the molecules and in assaying the chiral purity by instrumental methods. While diastereomers can have different physical properties including solubility, enantiomers have the same physical properties and the same chemical composition. How then to separate optically active molecules ... 

See Section IV.1 for alternative methods of chiral resolution. Partial chemical hydrolysis of proteins and peptides with hot 6 M HC1, followed by enzymatic hydrolysis with pronase, leucine aminopeptidase and peptidyl D-amino acid hydrolase, avoids racemiza-tion of the amino acids281. The problems arising from optical rotation measurements of chiral purity were reviewed. Important considerations are the nonideal dependence of optical rotation on concentration and the effect of chiral impurities282. 

The chiral purity of amino acids at large enantiomeric excess can be determined automatically by derivatization with 4-fluoro-7-nitro-2,l,3-benzoxadiazole (127b) followed by CE with cyclodextrin chiral selectors and detection of the LIF excitation at 488 nm. Lod 140 ppm of L-phenylalanine in D-phenylalanine324. 

The use of CLEA preparations of commercially available HNLs allowed for the enantiocomplementary production of cyanohydrins from a pyridinecarboxaldehyde at a much higher chiral purity than had previously been demonstrated with any chemical catalyst. The key to the success of this process was the use of the CLEA -immobilized biocatalysts that allowed reaction conditions to be chosen to minimize the negative effects of the nonspecific background reaction. 

Chiral CE can be widely applied in release and stability testing, the chiral purity of intermediates, and raw materials. Various generic method development approaches have been developed and published recently. " ... 

In Table 1, the typical validation parameters required for the different types of analytical procedures are listed. For all these analytical procedures CE might be an appropriate analytical technique. In fact numerous validated CE methods for pharmaceutical analysis have been described in literature during the last decade.In Table 2, an overview is listed of the ICH validation parameters included in several reported CE validation studies. Since chiral purity determination is an important application area of CE methods, this test is listed separately as a specific analytical procedure. In addition, the determination of drug counterions has been included as a separate application. This overview illustrates that in general the required validation parameters are addressed in reported CE validation studies. It should be noted, however, that the validation parameters included in Table 2 are not necessarily evaluated exactly according ICH requirements in the reported references. Many pharmaceutical companies apply a phase-related validation approach in which the depth of validation depends on the clinical phase of development of the product involved. 

CE is an important separation technique within the field of pharmaceutical analysis. CE may be an attractive choice as analytical procedure for identification, assay, or (chiral) purity determination. In addition, CE may provide distinct advantages over existing pharmacopoeial... 

Hammitzsch, M., Rao, R. N., and Scriba, G. K. E. (2006). Development and validation of a robust capillary electrophoresis method for impurity profiling of etomidate including the determination of chiral purity using a dual cyclodextrin system. Electrophoresis 27(21), 4334—4344. 

Hsu s group in Taiwan have developed a procedure for the synthesis of (Y)-2-amino-4-phenylbutanoic acid, the phenylalanine homologue with one additional methylene group. Hydantoinase and L-A-carbamoylase genes have been cloned from different Bacillus species and overexpressed in E. coli. Both the R- and the 5-enantiomers were cleaved by the hydantoinase, but only the 5-form of the A-carbamoyl amino acid was hydrolyzed by the second enzyme. The reactions could be run in a single pot, with successive addition of the two enzymes, and were successful in the sense of giving a product of high chiral purity. However, the yield was... 

Song et al. [62] reported poly-salen Co(III) complexes 18, 19 as catalyst for HKR (Figure 5) of terminal alkene epoxides. The polymeric catalysts provided product epoxides with excellent conversion (>49%) and high chiral purity (ee s, 98%) and the catalytic system could be recycled once with retention of activity and enantioselectivity. 

Figure 3.5 Measurement of the chiral purity of commercially available Jacobson s catalyst using a cyclodextrin-based CSP. (a) Lower trace / ,/ -enantiomer product upper trace / ,/ -enantiomer product artificially enriched with S -enantiomer and (b) lower trace S. S -enantiomer product upper trace S. S -enantiomer product artificially enriched with / ,/ -enantiomer. (Conditions CYCLOBOND 1 2000RSP 25 cm X 0.46 cm i.d. mobile phase acetonitrile triethylamine glacial acetic acid [1000 0.5 2.5, v/v] flow rate 1 ml/min temperature ambient detection UV at 240 nm sample preparation 1 mg/ml in acetonitrile injection volume 10 fxl). Reprinted from [19], copyright 1998, with permission of Wiley-Liss, Inc., a subsidiary of John Wiley and Sons, Inc.

Substrate/Product/Effector/Ligand Stereospecificity. Assessing the specificity for particular stereoisomers as substrates, products or effectors (surprisingly, effectors such as enzyme activators, rarely have their stereospecificities reported). In such studies, the investigators should clearly state the degree of chiral purity which is present and how it was determined. 

STEREOCHEMICAL TERMINOLOGY, lUPAC RECOMMENDATIONS CHIRAL METHYL GROUPS Chiral purity,... 

A majority of the chiral purity assays made with HPLC published during the last decade are based on separation on CSPs and subsequent UV detection (Table 17.3). The polysaccharide phases seem to be the dominating CSPs, but there is an even distribution in the methods that uses normal-and reversed-phase modes. A few of the methods utilize CMPA [39,59,60] or indirect separation by chemical derivatization [16,18]. However, it seems that the majority of the published papers... 

MIP assays can also be utilized in synthetic organic applications. For example, MIP-based assays have been used to measure the chiral purity of samples in organic solvents. An L-phenylalanine anilide (l-PAA) imprinted polymer was utilized as a recognition element to measure the enantiomeric excess (ee) of PAA samples (Chen and Shimizu 2002). The MIP displays greater capacity for l-PAA versus d-PAA samples of similar concentration, and this difference was used to estimate enantiomeric excess. The enantiomeric excess of an unknown solution was determined by comparing the UV absorbance of the PAA remaining in solution after equilibration against a calibration curve. This MIP assay was demonstrated to be rapid and accurate with a standard error of +5% ee. 

Much of the knowledge needed for manufacturing a pharmaceutical is related to the last step in the process, including understanding the bulk active ingredient, its impurity profile, chiral purity, and crystal form. To cut down the entire scale-... 

Drug Substance Chiral Purity III Zorbax silica 25 cm X 4.6 mm - 3pm Solvent A Methyl tert-butyl elher/ actonitrile/ water 967 30 3 (v/v/v) Solvent B Heptane 65% solvent A 35% solvent B 254 nm after derivatization 12. 

The classical methods for detection and quantitation of racemization require analysis of the chiral purity of the product of a peptide-bond-forming reaction. For example, the Anderson test is used to explore a variety of reaction conditions for the coupling of Z-Gly-Phe-OH to H-Gly-OEt (Scheme 6). 9 The two possible enantiomeric tripeptides are separable by fractional crystallization, so that gravimetric analysis furnishes the racemization data. This procedure has a detection limit of 1-2% of the epimerized tripeptide. A modification by Kemp,1"1 utilizing 14C-labeled carboxy components, extends the detection limit by two to three orders of magnitude by an isotopic dilution procedure. The Young test 11 addresses the coupling of Bz-Leu-OH to H-Gly-OEt, and the extent of epimerization is determined by measurement of the specific rotation of the dipeptide product. 

---